Jorge Santos da Silva is Chief Executive Officer; Interim Chair of the Board of MoonLake Immunotherapeutics (MLTX). The company reported total compensation of $4,943,209 for fiscal year 2025.
| Salary | $762,386 |
|---|---|
| Bonus | $0 |
| Stock awards | $4,000,021 |
| Option awards | $0 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $155,880 |
| All other compensation | $24,922 |
| Total | $4,943,209 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure MoonLake Immunotherapeutics filed April 21, 2026, accession 0001140361-26-015916.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer; Interim Chair of the Board | $762,386 | $0 | $4,000,021 | $0 | $0 | $155,880 | $24,922 | $4,943,209 |
| FY2024 | Chief Executive Officer; Interim Chair of the Board | $698,245 | $574,254 | $0 | $0 | $0 | $109,913 | $23,626 | $1,406,038 |
| FY2023 | Chief Executive Officer; Interim Chair of the Board | $586,333 | $589,819 | $0 | $0 | $0 | $0 | $22,063 | $1,198,215 |
Totals as disclosed in each year's own compensation disclosure for MoonLake Immunotherapeutics.
| Peer-group chief executive median | $10,732,127 |
|---|---|
| Difference from that median | $-5,788,918 |
| Percentile within the disclosed peer group | 1st |
| Peers with a disclosed figure | 3 |
Medians and percentiles are computed across the peer group MoonLake Immunotherapeutics discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Jorge Santos da Silva this page | Chief Executive Officer; Interim Chair of the Board | $4,943,209 |
| Kristian Reich | Chief Scientific Officer | $4,795,493 |
| Matthias Bodenstedt | Chief Financial Officer | $4,692,576 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full MoonLake Immunotherapeutics compensation brief.
Jorge Santos da Silva's compensation sits inside MoonLake Immunotherapeutics's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.